InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（13 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
13
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Robb Gary Charles, Directeur Commercial. Insider active across 2 companies, notably Corcept Therapeutics INC. In total, 61 disclosures have been logged. Split: 0 buy · 13 sells. Total volume traded: €4.9m. History available since 30 August 2021. The latest transaction was filed on 17 August 2026 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Robb Gary Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报61 总计
125 股0Common StockSEC:0001193125-26-355560:0
10,000 股@ US$116.25720.0092% mcap50.0% 占其流量Common StockSEC:0001193125-26-355560:1
3,000 股0Common StockSEC:0001193125-26-352428:1
11,530 股0Common StockSEC:0001193125-26-352428:0
3,000 股0Common StockSEC:0001193125-26-352428:2
600 股0Common StockSEC:0001193125-26-298871:0
776 股@ US$70.440.0004% mcap0.9% 占其流量Common StockSEC:0001193125-26-256002:0
358 股@ US$70.440.0002% mcap0.4% 占其流量Common StockSEC:0001193125-26-256002:2
776 股0Common StockSEC:0001193125-26-256002:1
1,000 股0Common StockSEC:0001193125-26-227411:1
1,000 股0Common StockSEC:0001193125-26-227411:2
5,300 股0Common StockSEC:0001193125-26-227411:0
499 股@ US$35.970.3% 占其流量Common StockSEC:0001193125-26-092158:0
145,000 股@ US$3.888.2% 占其流量Common StockSEC:0001193125-25-335575:0
224 股@ US$79.780.3% 占其流量Common StockSEC:0001193125-25-307213:0
251 股@ US$71.380.3% 占其流量Common StockSEC:0001193125-25-196309:0
5,000 股@ US$3.880.3% 占其流量Common StockSEC:0001193125-25-188869:0
3,185 股@ US$70.773.7% 占其流量Common StockSEC:0000950170-25-088005:0
997 股@ US$71.681.2% 占其流量Common StockSEC:0000950170-25-081932:0
2,279 股@ US$75.853.0% 占其流量Common StockSEC:0000950170-25-076417:0
313 股0Common StockSEC:0000950170-25-057620:0
233 股0Common StockSEC:0000950170-25-044069:0
4,625 股0Common StockSEC:0000950170-25-039604:0
250 股@ US$60.580.3% 占其流量Common StockSEC:0000950170-25-032708:0
11,000 股@ US$3.290.7% 占其流量Common StockSEC:0000950170-25-002439:0
61 条申报中的 25 条
About Robb Gary Charles
Robb Gary Charles is Directeur Commercial at CORCEPT THERAPEUTICS INC, where he is also listed as Chief Business Officer. He has 56 filings in total, and among the recent sampled filings, the period runs from 2021-09-01 to 2026-07-08, with EUR 0 in buys and EUR 3,883,482 in sales; the most frequent transaction nature is Don.
